Impact of Medication Adherence and Persistence on Clinical and Economic Outcomes in Patients with Type 2 Diabetes Treated with Liraglutide: A Retrospective Cohort Study
Conclusions
Adherence and persistence to liraglutide are associated with improved A1C outcomes. Persistent patients showed significantly lower medical costs versus those discontinuing liraglutide. Total healthcare costs were higher for adherent and persistent cohorts driven by higher pharmacy costs.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Diabetes | Diabetes Type 2 | Drugs & Pharmacology | Endocrinology | Healthcare Costs | Insulin | Study | Victoza